DNAnexus, which provides a data analysis and management platform for DNA sequence data, announced it has secured $100 million in a round co-led by Perceptive Advisors and Northpond Ventures. DNAnexus says the funds will advance its international growth, enabling the company to serve health care and life science organizations around the world as it grows its cloud-based clinical testing offerings. A number of DNAnexus customers — which include eight of the top 10 clinical diagnostics companies, seven of the top 10 pharmaceutical companies, and over 100 enterprises — tap the platform for machine learning applications. These perform AI-aided variant calls, which entail identifying substitutions of single nucleotides (the building blocks of DNA) and small insertions and deletions from next-generation sequencing data. They rely on deep learning for pathology processing, medical record interpretation, and extracting insights out of large-scale data proteomics (the study of proteins) and metabolomics (the study of the products of metabolism) data. Investors in DNAnexus’ latest funding round include GV (formerly Google Ventures), Foresite Capital, TPG Capital, First Round Capital, and first-time equity investor Regeneron Pharmaceuticals. This series G round brings the company’s total raised to over $270 million, following a $68 million series F in February 2019.
Geisinger Health System has inked a 10-year technology agreement with Siemens Healthineers to access diagnostic imaging equipment and artificial intelligence applications. The Danville, Pennsylvania-based health system said the partnership will advance and support elements of its strategic priorities related to continually improving care for their patients, communities and the region. The medical technology company will provide Geisinger access to its latest digital health innovations, diagnostic imaging equipment and on-site staff to support improvements. Education and workflow resources will also be available, which will provide Geisinger staff with the ability to efficiently make decisions and continually optimize workflows, the companies said. "Making better health easier by bringing world-class care close to home is central to everything we do at Geisinger,” said Matthew Walsh, chief operating officer at Geisinger. “This partnership will allow us to continue to equip our facilities with the most advanced diagnostic imaging technology in the market to care for our patients.”
Headlines curated and edited by Seth Schachter, Associate at DeciBio Consulting
If you would like to discuss the field of big data and AI in healthcare in more detail or provide feedback on our newsletters, please don't hesitate to reach out to me at Schachter@decibio.comor connect with me on LinkedIn
